What is Emtricitabine (FTC)?

Category: Prescription Drugs

Most popular types: Emtriva Coviracil

false

Emtricitabine is a nucleoside reverse transcriptase inhibitor used in the treatment of HIV infection in combination with at least two other antiretroviral agents. It may also be used for Hepatitis B (with HIV coinfection).

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 1
None 1

Commonly reported side effects and conditions associated with Emtricitabine (FTC)

Side effect Patients

Why patients stopped taking Emtricitabine (FTC)

Multiple reasons could be selected

Reason Patients
Course of treatment ended 1
See all 1 patient who’ve stopped taking Emtricitabine (FTC)

Duration

Stopped taking Emtricitabine (FTC)

Duration Patients
6 months - 1 year 1
Adherence
Adherence Evaluations
Always 1
Usually 1
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 0
Not at all hard to take 2
Cost per month
Cost per month Evaluations
$200+ 0
$100-199 0
$50-99 0
$25-49 1
< $25 1
Not specified 0

What people switch to and from

Patients started taking Emtricitabine (FTC) after stopping:

Treatment Patients
Efavirenz-Emtricitabine-Tenofovir (Atripla) 1
Last updated:
There are no evaluations for Emtricitabine (FTC).